24 h from the onset of acute symptoms'. We sent a second letter to these facilities to reinforce the registration of these patients at the end of the first year.
Second, we visited 11 major hospitals in the study area to identify patients with AMI or sudden death; 10 of these hospitals have coronary arteriographic facilities and are equipped for acute coronary care. The majority of coronary patients who had escaped sudden death would have been transported from small clinics to these hospitals. The remaining hospital is a general hospital located northeast of Niigata city, which we included although it has neither coronary arteriographic facilities nor a coronary care unit, but it is an emergency medical care center and some acute coronary patients may have been transported there.
Approximately 1-3 months after the incidence of AMI or sudden death, we visited the medical facility that had reported the event, and using the criteria of the WHO-MONICA project, we reviewed the medical chart to confirm diagnosis and prognosis on the 28th day. [9] [10] [11] The events were classified into the following categories: (1) nonfatal definite AMI, (2) fatal definite AMI, (3) fatal possible coronary event, (4) unclassifiable fatal event of unknown cause, and (5) non-CHD. Each case was also classified into definite AMI, and the lesion was identified by coronary arteriography, although some of the cases had not satisfied the requirements for the diagnosis according to the original MONICA criteria for which coronary arteriography findings were not taken into account.
Death Certificate Review Survey We reviewed all death certificates in Niigata and Nagaoka cities during the study period, and all sudden death cases were classified by the rule developed by Toyoshima et al. 12, 13 Briefly, every disease, symptom, and sign, except for the common cold, was nominated as a cause of death if the date of onset was within 30 days before death. Cancer was also nominated as a cause of death irrespective of the date of the onset. Next, a single main cause of death was chosen according to the following series of priorities: (1) AMI, (2) rupture of an aortic aneurysm, (3) stroke, (4) cancer, (5) the earliest onset of specific diseases such as upper digestive hemorrhage, acute renal failure and acute pneumonia, (6) the earliest onset of other organic diseases, (7) the earliest symptom or sign such as chest pain, acute heart failure, cardiac arrest, and (8) unknown cause. If cancer was chosen as the main cause of death, the case was excluded from the sudden death category. Finally, if the onset of the main cause of death was within 24 h of death, each of these cases was recorded as sudden death for further analysis.
Calculation of Event Rate
From all sudden death events we estimated the total number of fatal AMI, possible coronary events and unclassifiable fatal events by multiplying each proportion from the registration survey by total events from the death certificate survey (Fig 1) . These were combined with the number of non-sudden death events in the registration survey and categorized by adopting the criteria in WHO-MONCA project. The registered number of nonfatal definite AMI events in the registration survey (A in Fig 1) was categorized into NF1. The registered number of nonsudden-death fatal definite AMI events in the registration survey (B in Fig 1) was added to the estimated number of The sex-specific event rate was obtained for each age group in 5-year intervals from ages 35 to 64 years. Then, the annual age-adjusted event rate was computed directly by applying the world population as the standard. 14 To calculate 95% confidence intervals of event rates, normal approximation of the Poisson distribution was used. 15 
Results

Registration Survey
From the registration survey a total of 122 nonfatal cases of definite AMI, 4 fatal cases of non-sudden-death definite AMI, and 136 cases of sudden death were recorded (Table 1) . Among the sudden death cases, 8 (5.9 %) were diagnosed as definite AMI, 19 (14.0%) as a possible coronary event, and 51 (37.5%) as unclassifiable fatal events.
Death Certificate Review Survey and Combination Analysis With Registration Survey
In the death certificate survey 318 cases of sudden death were included (Table 1 ). The number of sudden-death definite AMI events, sudden-death possible coronary events and unclassifiable fatal events was estimated to be 18.7, 44.4 and 119.3, respectively.
Event Rates
When data from the registration survey alone were adopted for the calculation, crude event rates of total AMI and coronary death (per 100,000 /year) in the 15-65 years age group were calculated to be 21.2 (37.2 for men and 5.6 for women) according to definition 1, and 15.9 (28.1 for men and 3.9 for women) according to definition 2. The ageadjusted event rates (per 100,000 /year) from the 35-64 years age group were 30.3 (54.6 for men and 7.2 for women) according to definition 1, and 23.1 (41.9 for men and 5.3 for women) according to definition 2 ( Table 2) .
By applying the estimation to the data including the certificate review survey, the crude event rate (per 100,000 /year) increased to 32.1 (54.7 for men and 9.8 for women) according to definition 1, and 19.7 (33.9 for men and 5.7 for women) according to definition 2. Consequently, the estimated age-adjusted event rate (per 100,000 /year) was increased to 45.8 (80.6 for men and 14.2 for women) according to definition 1, and 28.6 (50.0 for men and 9.0 for women) according to definition 2 ( Table 2) .
Discussion
In the WHO-MONICA project, annual event rates of AMI and coronary deaths according to definition 1 (per 100,000 age-adjusted, 35-64 years) were 76 (Beijing, China) to 915 (North Karelia, Finland) for men, and 30 (Catalonia, Spain) to 266 (Glasgow, UK) for women. 11 Our data for the age-adjusted event rates ranked as the second lowest for men (80.6) and the lowest (14.2) for women in comparison with these populations. Other studies in Japan also recorded this low event rate. 16, 17 A multicenter study covering 25 districts of Japan reported that the annual event rate (per 100,000 age-adjusted, 35-64 years) according to definition 1 was 34.1 for men and 6.6 for women. 16 A study conducted in the Shibata-district of Niigata prefecture indicated that the annual event rate according to definition 1 was 95 for men and 27 for women. 17 Thus, very low event rates of AMI and coronary deaths are characteristic not only for the present study population, but also for the Japanese population in general.
The finding of a low event rate from AMI and coronary deaths in Niigata and Nagaoka cities in the present report is consistent with lower mortality in Japan, as reported by others. 5, 6 It has been suggested that the low mortality from CHD in Japan may be partly explained mainly by the low intake of saturated fat 18, 19 and low serum cholesterol concentrations. 20, 21 Effects of genetic and environmental factors on CHD in the Japanese race was investigated approximately 30 years ago by the Ni-Hon-San study, which compared CHD rates and risk factors in Japanese men living in Nippon (ie, Japan), Honolulu (Hawaii), and San Francisco (California). [22] [23] [24] [25] [26] [27] The investigators demonstrated that such CHD rates as mortality, 22 prevalence 23 and incidence 24 were lowest in Japan, intermediate in Hawaii and the highest in California, and that gradients in CHD risk factors such as weight, serum cholesterol and glucose concentrations, and blood pressure were similar to the gradients in disease rates. 23, [25] [26] [27] Because all study subjects were Japanese, these differences were explained by environmental factors, particularly diet, the main differences being the increased intake of animal protein and saturated fat and decreased intake of carbohydrate by Japanese Americans. 25 During the decades following the Ni-Hon-San study, a rapid increase in the intake of saturated fat and a decrease in that of carbohydrate have led to an increase in the mean serum cholesterol concentration in the Japanese population. [1] [2] [3] Although these vertical changes resemble the horizontal difference between native Japanese and Japanese Americans as shown in the Ni-Hon-San study, there has been no evidence that CHD rates have been increasing in Japan; on the contrary, the mortality from CHD has been decreasing, 5, 6 while the CHD incidence in some cohort studies has been stable for the few decades before the present study. 28, 29 A recent study by Namekata et al revealed that total and low density lipoprotein (LDL)-cholesterol concentrations remain much lower in native Japanese than in Japanese Americans in Seattle, as well as the general American population. 30 Thus, serum cholesterol concentrations in the Japanese population might not have reached levels that would significantly influence CHD rates, or not enough time has elapsed to observe such effects on CHD among the Japanese population.
Because multiple factors are associated with CHD, the low rates in Japan cannot just be simply explained by the serum concentrations of total or LDL cholesterol. However, the Japanese population has been reported to have a favorable profile of CHD risk factors, including higher concentrations of serum high density lipoprotein (HDL)-cholesterol, a lower total serum cholesterol/HDL-cholesterol ratio, a low prevalence of obesity, and relatively low prevalence of diabetes in women. Also, a higher serum composition of omega-3 fatty acid, which is considered to be a protective factor for CHD, has been found in native Japanese than in American subjects. 21, [30] [31] [32] [33] [34] Some Japanese foods have also been reported to have potentially protective effects against CHD. 35 The combined effects of all these factors as well as the extensive chronic disease prevention screening program throughout Japan may have contributed to the low rate of CHD in the Japanese population, reflected by the low event rates of AMI and coronary deaths in the present study.
Study Limitations
There are 2 major limitations in the present study. First, we could not review a medical chart for every suddendeath case included in the death certificate review survey because the institutional policy in Japan does not permit access to medical facilities holding personal information on death certificates. The WHO-MONICA project revealed that the death diagnosis on the certificate could not be used for the classification of a coronary event for the project. 11 Furthermore, the reliability of the death diagnosis of AMI altered in Japan during our study period because of the revision in 1995 of the death certificate form. The revised form encourages doctors to avoid the use of 'heart failure' as the cause of death, so mortality recorded as heart failure has decreased drastically, but mortality from coronary heart disease has increased. 36, 37 We reported that sudden death from unknown causes had been diagnosed mainly as heart failure before the revision, but tended to be diagnosed as AMI after the revision in our study area. 37, 38 We then estimated the number of events for each category of sudden death by applying the proportion of registered sudden death events to the total events from the certificate review rather than using death diagnosis itself. To assess the validity of the estimation, we compared major causes of death determined by the death certificate review survey between registered and non-registered sudden death cases. When the causes of death were classified as AMI, aortic disease, other cardiovascular disease, stroke, and non-circulatory disease, there was no statistical difference in the proportions between registered and non-registered sudden-death groups. This result supports the validity of our estimation procedure.
Second, we could have missed some cases of nonsudden-death AMI in our registration survey. We hypothesized that the majority of non-sudden-death events would have accumulated in the 10 hospitals that had coronary arteriographic care facilities, as non-sudden-death cases would probably have been transported to one of these hospitals if they had visited another medical facility first. Thus, we regularly visited these hospitals to identify such cases. We also regularly visited the other general hospital, in Niigata city, although it was not specialized for urgent coronary care, but we did not find any cases of non-suddendeath AMI at this hospital. This fact supports our hypothesis that most non-sudden-death AMI cases were sent to the 10 coronary care unit hospitals. However, there remains a possibility that we may have missed some patients with non-sudden-death AMI who were admitted to medical facilities other than the 11 regularly monitored hospitals, because the Japanese medical insurance system allows every hospital or clinic to care for a patient with AMI regardless of its facilities for coronary care. If we could have estimated registration rate of non-sudden-death AMI events by comparing fatal events between the death certificate review and the registration survey, we also could estimate the total number of non-sudden-death AMI events as we did for sudden-death events. Regarding non-sudden-death AMI, 4 events were found by our death certificate review, including an event which was diagnosed in a surgical ward within a few days after surgery for pancreatic cancer. Although this special case was missed, the other 3 events found in the certificate review were identified in the registration survey. However, the number of fatal events was too few to estimate a registration rate; therefore, it is possible that the number of non-suddendeath AMI events could have been underestimated. Further investigations are required to solve these problems.
The present report revealed 126 non-sudden-death AMI and 136 sudden deaths identified by our registration survey, with 318 sudden deaths identified by the death certificate survey. According to the stated limitations, we could have missed some cases, but we believe that this was too small to affect our overall estimation, although we will to continue to improve our data collection method for future studies.
Conclusion
Event rates of AMI and coronary deaths are very low in Niigata and Nagaoka cities, Japan, compared with those in other industrialized nations reported in the WHO-MONICA project. Our findings are consistent with those of other studies in Japan reporting low event rates of AMI and coronary deaths.
